Kaplan–Meier analysis revealed significantly reduced relapse-free survival (RFS) (p < 0.05) in 373 patients with ERα positive breast cancer with high NgBR expression in tumors as compared to 382 patients with low NgBR expression in tumors. Here, ESR1 is linked to breast cancer.